CN106722444A - 一种沙棘咀嚼片的制作方法 - Google Patents
一种沙棘咀嚼片的制作方法 Download PDFInfo
- Publication number
- CN106722444A CN106722444A CN201611023842.4A CN201611023842A CN106722444A CN 106722444 A CN106722444 A CN 106722444A CN 201611023842 A CN201611023842 A CN 201611023842A CN 106722444 A CN106722444 A CN 106722444A
- Authority
- CN
- China
- Prior art keywords
- sea
- buckthorn
- preparation
- tablet
- chewing tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000003145 Hippophae rhamnoides Nutrition 0.000 title claims abstract description 112
- 230000001055 chewing effect Effects 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 240000000950 Hippophae rhamnoides Species 0.000 title abstract description 4
- 241000229143 Hippophae Species 0.000 claims abstract description 111
- 239000000843 powder Substances 0.000 claims abstract description 44
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 37
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 24
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 24
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 229930003944 flavone Natural products 0.000 claims abstract description 17
- 150000002213 flavones Chemical class 0.000 claims abstract description 17
- 235000011949 flavones Nutrition 0.000 claims abstract description 17
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 12
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims abstract description 11
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000001630 malic acid Substances 0.000 claims abstract description 11
- 235000011090 malic acid Nutrition 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 11
- 239000004375 Dextrin Substances 0.000 claims abstract description 10
- 229920001353 Dextrin Polymers 0.000 claims abstract description 10
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims abstract description 10
- 239000001527 calcium lactate Substances 0.000 claims abstract description 10
- 229960002401 calcium lactate Drugs 0.000 claims abstract description 10
- 235000011086 calcium lactate Nutrition 0.000 claims abstract description 10
- 235000019425 dextrin Nutrition 0.000 claims abstract description 10
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 8
- 235000015165 citric acid Nutrition 0.000 claims abstract description 8
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract description 8
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims description 34
- 238000001035 drying Methods 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000005469 granulation Methods 0.000 claims description 14
- 230000003179 granulation Effects 0.000 claims description 14
- 239000007779 soft material Substances 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 239000000080 wetting agent Substances 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 6
- 239000000314 lubricant Substances 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 2
- 238000011017 operating method Methods 0.000 abstract description 2
- 239000007910 chewable tablet Substances 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 230000000717 retained effect Effects 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 23
- 235000019198 oils Nutrition 0.000 description 23
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 10
- -1 phytosterol Chemical class 0.000 description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 150000003431 steroids Chemical class 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 6
- 239000011709 vitamin E Substances 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 235000005979 Citrus limon Nutrition 0.000 description 4
- 244000131522 Citrus pyriformis Species 0.000 description 4
- UZBSAVZYILSDDH-ADGVWNIHSA-N Ergostene Chemical compound C[C@H](CC[C@H](C)C(C)=C)[C@H]1CC[C@H]2[C@@H]3CCC4CCCC[C@]4(C)[C@H]3CC[C@]12C UZBSAVZYILSDDH-ADGVWNIHSA-N 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 238000007873 sieving Methods 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000003935 Hippophae Nutrition 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 244000143590 Salvia chinensis Species 0.000 description 3
- 235000007154 Salvia chinensis Nutrition 0.000 description 3
- 235000005794 Salvia japonica Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 150000007965 phenolic acids Chemical class 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- DJOWTWWHMWQATC-KYHIUUMWSA-N Karpoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1(O)C(C)(C)CC(O)CC1(C)O)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C DJOWTWWHMWQATC-KYHIUUMWSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- OSELKOCHBMDKEJ-UHFFFAOYSA-N (10R)-3c-Hydroxy-10r.13c-dimethyl-17c-((R)-1-methyl-4-isopropyl-hexen-(4c)-yl)-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 OSELKOCHBMDKEJ-UHFFFAOYSA-N 0.000 description 1
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- MCWVPSBQQXUCTB-UHFFFAOYSA-N (24Z)-5alpha-Stigmasta-7,24(28)-dien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(=CC)C(C)C)CCC33)C)C3=CCC21 MCWVPSBQQXUCTB-UHFFFAOYSA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000013479 Amaranthus retroflexus Nutrition 0.000 description 1
- 244000055702 Amaranthus viridis Species 0.000 description 1
- 235000004135 Amaranthus viridis Nutrition 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000009344 Chenopodium album Nutrition 0.000 description 1
- 235000005484 Chenopodium berlandieri Nutrition 0.000 description 1
- 235000009332 Chenopodium rubrum Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 240000004350 Prunus spinosa Species 0.000 description 1
- 235000010829 Prunus spinosa Nutrition 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- FSLPMRQHCOLESF-SFMCKYFRSA-N alpha-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C FSLPMRQHCOLESF-SFMCKYFRSA-N 0.000 description 1
- SJMCNAVDHDBMLL-UHFFFAOYSA-N alpha-amyrin Natural products CC1CCC2(C)CCC3(C)C(=CCC4C5(C)CCC(O)CC5CCC34C)C2C1C SJMCNAVDHDBMLL-UHFFFAOYSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003402 anti-promotion Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- MCWVPSBQQXUCTB-OQTIOYDCSA-N avenasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CC/C(=C/C)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 MCWVPSBQQXUCTB-OQTIOYDCSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 150000002121 epoxyeicosatrienoic acids Chemical class 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000011170 pharmaceutical development Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 125000005633 phthalidyl group Chemical group 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明提供了一种沙棘咀嚼片的制作方法，咀嚼片主要包括：沙棘粉45‑60g，羧甲基纤维素钠3‑8g，柠檬酸1‑3g，苹果酸1‑3g，糖霜40‑60g，糊精45‑55g，乳酸钙3‑7g，黄酮粉2‑5g，硬脂酸镁0.5‑2g，搅拌混匀后造粒，压片机压片。本方法操作工艺简单、产品风味好，可以完整地保留沙棘营养成分，提高了沙棘中黄酮含量到0.5％，是一种新的保健功能高的沙棘产品，延长了沙棘销售时间，拓宽了沙棘产品种类，更大的提高了沙棘市场价值，市场前景非常好。
Description
技术领域
本发明涉及食品加工领域，特别地，涉及一种沙棘咀嚼片的制作方法。
背景技术
沙棘，胡颓子科植物。俗称醋柳，酸刺，黑刺。每100g含有可溶性糖8g～12g、有机酸1g～3g、类胡萝卜素3～4g、维生素C300mg、维生素E15mg，特别是还含有丰富的微量元素、沙棘黄酮、植物甾醇、酚类及有机酸类、三萜、甾体类化合物等许多活性物质，具有多方面的功效。可被应用于防治心脑血管疾病、肿瘤、免疫性疾病、肠胃消化道疾病等，还具有显著的抗衰老、抗感染和促进组织细胞再生作用，具有很大的医药开发价值。
沙棘果油是通过一定的物理手段从沙棘中提取出来的物质，它是一种高营养、高经济价值的天然物质。其含有多种维生素、多种微量元素、多种氨基酸和其他生物活性物质。前苏联学者研究发现沙棘油中所含的活性成分已达1060种(其中脂溶性维生素6种，脂肪酸22种，脂类42种，黄酮和酚类36种。其己经分离鉴定出的主要成分大致可分为维生素类：主要有维生素E、维生素A、维生素A原(胡萝卜素)、维生素K、维生素C、维生素F等。梁德年等研究结果表明100g沙棘果中含维生素c580mg-800mg，而且所含的维生素c相当稳定。维生素A在沙棘中的含量也是非常丰富的，阿塞拜疆产的沙棘每百克干燥果渣中含40mg，在沙棘油中含168mg-215mg。果渣中含总生育酚28mg，在油中含总生育酚112mg-154mg。维生素E最有活性的是占维生素51％一65％的维生素E-α型，维生素E族是沙棘油天然抗氧化剂，含量越高，沙棘油越稳定。三萜、甾醇类化合物：沙棘油中含有约52中此类的成分，主要包括谷甾醇、香树精、环羊毛甾醇、麦角甾烯二醇、熊果酸、环一羊毛甾二醇、豆甾二烯酮、麦角甾烯醇、麦角甾烯四醇、24一甲基环阿尔他醇、柠黄醇、豆甾烯醇(△7)、燕麦甾醇(△5、△7)、菜油烯醇(△7)、菜油甾醇等。殷福珊等采用硅胶柱层析和色质联用技术对沙棘籽油不皂化部分进行了分析，鉴定除维生素E和10个甾类化合物:如环-羊毛甾-二醇、豆甾二烯酮、麦角甾烯醇、麦角甾烯四醇等。同时证明了沙棘籽油中也含有与果油相同的成分，如α-香树精、β-香树精、环-羊毛甾一二醇、麦角甾烯醇二醇等。脂类成分：沙棘油中含有大量脂肪酸，含量达60-70％，主要有硬脂酸、软脂酸、油酸、亚油酸、亚麻酸、花生酸、肉豆蔻酸、棕榈烯酸、月桂酸等；此外，沙棘油中还含有13种单羟基和4种双羟基酸，以及7种单，双和三环氧酸；沙棘中含有100多种类脂成分，沙棘油中磷脂含量为0.9-1.0％。包括卵磷脂、脑磷脂、磷脂酞胆碱、磷脂酞甘油、磷脂酞基醇、磷脂酞胆胺、溶血磷脂酞基醇、溶血卵磷脂、N一酞基磷脂酞醇、溶血N一乙酞磷脂酸胆胺等。黄酮类成分：沙棘果和叶中黄酮类成分已被鉴定的有槲皮素、异鼠李素、山奈酚及其苷类、杨梅酮、氯原酸、猪草苷、儿茶酸、黄芪苷等，不同的沙棘品种，不同部位和不同的产地沙棘资源，黄酮含量不同；果实成熟度、采收期对黄酮类成分也有重要影响。酚类和有机酸：沙棘油中含有苹果酸、柠檬酸、草酸、酒石酸、琥珀酸等有机酸成分，总含量为3.86-4.52％。其多酚类化合物包括乌索酸、a-香豆素、香豆素、酚酸、鼠尾草酚、鼠尾草酚酸、n-甲基鼠尾草酚酸等。挥发油类成分：成熟新鲜的中国经水汽蒸馏得浅黄色有状物。收率为175mg/Kg，冷却后凝固为半固体，经TLC表明该油含有较多的游离脂肪酸和极性很小的烃类成分。采用GC-MS方法分析其化学组成，在所给出的89个峰中，己鉴定除82个化合物。迄今己从中国沙棘、鼠李沙棘及肋果沙棘中鉴定除200多种挥发性成分。芬兰产沙棘果中含挥发性成分36种组分，分析出60种芳香成分，主要是低级脂肪酸脂。陕西黄龙去籽中国沙棘含挥发油成分1.23-1.69％，检出36种组分，确定了其中的32种。青海祁连县肋果沙棘精油出油率为0.1-0.14％，鲜果精油含量大于0.1％的组分有160余种，初步鉴定出52种，含量占精油总组成的80％以上，其中醇、醛、低级脂肪酸脂类占相当比例。微量元素：沙棘油中含有30多种微量元素，其中包括人体必须的微量元素，如铁、锌、锰、铝、硒、镍、锡、硅、矾等。其他成分：沙棘油中还含有酯、醚、醛、酮、同时烯烃和其他杂环化合物；同时还有碳氢类化合物，主要是cl6-34的直链烷烃。
沙棘是医食两用植物，有很高的经济价值和开发潜力，《中国药典》、藏医名著《四部医典》中都对沙棘的功效有明确记载。沙棘油提取自沙棘果实或种子，含有多不饱和脂肪酸和其他生物活性成分。因此，沙棘油作为特种功能性油脂，在食品、医药保健品、化妆品等领域有广泛的应用前景。沙棘油作为产业链的源头，对其深度开发具有至关重要的作用。对心血管系统的作用：沙棘油具有抗心肌缺氧的作用，可以延长小鼠的存活时间，对心肌缺血也有一定的保护作用。沙棘全成分62.08mg/kg腹腔注射，均能显著地提高小鼠耐缺氧能力，表现为小鼠存活时间显著延长，耗氧速度和残余氧量也较对照组有显著差异，而31.04mg/kg静脉给药对大鼠急性心肌缺血具有明显的保护作用。抗肿瘤方面的作用；沙棘油有明显的抗辐射作用；保肝作用实验报道，沙棘浓缩果汁和沙棘籽油有明显的保肝作用；棘油对动物性炎症有较明显的效果：沙棘油腹腔注射有抗氧化的作用和防止脂肪肝作用，能调节组织中脂质过氧化作用的速度和维生素E水平。沙棘油和维生素E相似，对高酷血清损伤的血管平滑肌细胞有保护作用，能明显降低高酷耗伤平滑肌细胞内增高的脂质过氧化物的含量，并能明显提高SOD的活性，能减轻高酷血清对细胞膜的损伤，保护并促进细胞的健康生长；沙棘还具有免疫增强作用。
为提高沙棘的利用效果，延长沙棘销售时间，拓宽沙棘产品种类，提升沙棘的经济价值，有必要对沙棘的深加工做进一步的研究。
发明内容
本发明目的在于提供一种沙棘咀嚼片的制作方法，以解决技术问题。
一种沙棘咀嚼片的制作方法，包括以下步骤：沙棘粉→干燥→粉碎→过筛→混合→造粒→干燥→压片→灭菌→包装→成品。
优选的，所述的粉碎，包括以下步骤：将干燥后的沙棘粉投入粉碎机中粉碎，过80目筛即得到沙棘果粉基料；同时将辅料经粉碎机粉碎后，过80目筛备用。
优选的，所述的混合，包括以下步骤：将粉碎后的沙棘果粉基料和辅料混合。
优选的，所述的造粒，包括以下步骤：将混合均匀的沙棘果粉基料和辅料，缓慢加入润湿剂制成软料，制好的软料过10目筛制粒。
优选的，所述的润湿剂为乙醇。
优选的，所述的干燥，包括以下步骤：将湿粒置于45-50℃热风干燥箱中干燥，25-30min翻动一次，以加快干燥速度，干燥终点以颗粒水分降至3-5％为宜。
优选的，所述的压片，包括以下步骤：在干燥颗粒中加入硬脂酸镁作为润滑剂，混合均匀，送入压片机中压片，灭菌后包装，即为成品。
优选的，所述的辅料，包括以下主要成分：糖霜、羧甲基纤维素钠、苹果酸、糊精、黄酮粉、乳酸钙、柠檬酸。
优选的，所述的沙棘咀嚼片包括以下重量比的成分：沙棘粉45-60g，羧甲基纤维素钠3-8g，柠檬酸1-3g，苹果酸1-3g，糖霜40-60g，糊精45-55g，乳酸钙3-7g，黄酮粉2-5g，硬脂酸镁0.5-2g。
进一步优选的，所述的沙棘咀嚼片包括以下重量比的成分：沙棘粉50g，羧甲基纤维素钠5g，柠檬酸2g，苹果酸2g，糖霜50g，糊精50g，乳酸钙5g，黄酮粉4g，硬脂酸镁1g。
本发明具有以下有益效果：本发明的沙棘咀嚼片的制作方法，操作工艺简单、产品风味好，可以完整地保留沙棘营养成分，提高了沙棘中黄酮含量到0.5％，是一种新的保健功能高的沙棘产品，延长了沙棘销售时间，拓宽了沙棘产品种类，更大的提高了沙棘市场价值，市场前景非常好。
除了上面所描述的目的、特征和优点之外，本发明还有其它的目的、特征和优点。下面将对本发明作进一步详细的说明。
具体实施方式
以下对本发明的实施例进行详细说明，但是本发明可以根据权利要求限定和覆盖的多种不同方式实施。
实施例1
一种沙棘咀嚼片的制作方法，包括以下步骤：沙棘粉→干燥→粉碎→过筛→混合→造粒→干燥→压片→灭菌→包装→成品。
所述的粉碎，包括以下步骤：将干燥后的沙棘粉投入粉碎机中粉碎，过80目筛即得到沙棘果粉基料；同时将辅料经粉碎机粉碎后，过80目筛备用。
所述的混合，包括以下步骤：将粉碎后的沙棘果粉基料和辅料混合。
所述的造粒，包括以下步骤：将混合均匀的沙棘果粉基料和辅料，缓慢加入润湿剂制成软料，制好的软料过10目筛制粒。
所述的干燥，包括以下步骤：将湿粒置于48℃热风干燥箱中干燥，27min翻动一次，以加快干燥速度，以颗粒水分降至4％为干燥终点。
所述的压片，包括以下步骤：在干燥颗粒中加入硬脂酸镁作为润滑剂，混合均匀，送入压片机中压片，灭菌后包装，即为成品。
所述的润湿剂为乙醇。
所述的沙棘咀嚼片，包括以下重量比的成分：沙棘粉50g，羧甲基纤维素钠5g，柠檬酸2g，苹果酸2g，糖霜50g，糊精50g，乳酸钙5g，黄酮粉4g，硬脂酸镁1g。
实施例2
一种沙棘咀嚼片的制作方法，包括以下步骤：沙棘粉→干燥→粉碎→过筛→混合→造粒→干燥→压片→灭菌→包装→成品。
所述的粉碎，包括以下步骤：将干燥后的沙棘粉投入粉碎机中粉碎，过80目筛即得到沙棘果粉基料；同时将辅料经粉碎机粉碎后，过80目筛备用。
所述的混合，包括以下步骤：将粉碎后的沙棘果粉基料和辅料混合。
所述的造粒，包括以下步骤：将混合均匀的沙棘果粉基料和辅料，缓慢加入润湿剂制成软料，制好的软料过10目筛制粒。
所述的干燥，包括以下步骤：将湿粒置于50℃热风干燥箱中干燥，25min翻动一次，以加快干燥速度，以颗粒水分降至5％为干燥终点。
所述的压片，包括以下步骤：在干燥颗粒中加入硬脂酸镁作为润滑剂，混合均匀，送入压片机中压片，灭菌后包装，即为成品。
所述的润湿剂为乙醇。
所述的沙棘咀嚼片，包括以下重量比的成分：沙棘粉45g，羧甲基纤维素钠8g，柠檬酸1g，苹果酸1g，糖霜40g，糊精55g，乳酸钙3g，黄酮粉5g，硬脂酸镁0.5g。
实施例3
一种沙棘咀嚼片的制作方法，包括以下步骤：沙棘粉→干燥→粉碎→过筛→混合→造粒→干燥→压片→灭菌→包装→成品。
所述的粉碎，包括以下步骤：将干燥后的沙棘粉投入粉碎机中粉碎，过80目筛即得到沙棘果粉基料；同时将辅料经粉碎机粉碎后，过80目筛备用。
所述的混合，包括以下步骤：将粉碎后的沙棘果粉基料和辅料混合。
所述的造粒，包括以下步骤：将混合均匀的沙棘果粉基料和辅料，缓慢加入润湿剂制成软料，制好的软料过10目筛制粒。
所述的干燥，包括以下步骤：将湿粒置于45℃热风干燥箱中干燥，30min翻动一次，以加快干燥速度，以颗粒水分降至3％为干燥终点。
所述的压片，包括以下步骤：在干燥颗粒中加入硬脂酸镁作为润滑剂，混合均匀，送入压片机中压片，灭菌后包装，即为成品。
所述的润湿剂为乙醇。
所述的沙棘咀嚼片，包括以下重量比的成分：沙棘粉60g，羧甲基纤维素钠3g，柠檬酸3g，苹果酸3g，糖霜60g，糊精45g，乳酸钙7g，黄酮粉2g，硬脂酸镁2g。
以上所述仅为本发明的优选实施例而已，并不用于限制本发明，对于本领域的技术人员来说，本发明可以有各种更改和变化。凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (10)
1.一种沙棘咀嚼片的制作方法，其特征在于，包括以下步骤：沙棘粉→干燥→粉碎→过筛→混合→造粒→干燥→压片→灭菌→包装→成品。
2.如权利要求1所述的沙棘咀嚼片的制作方法，其特征在于，所述的粉碎，包括以下步骤：将干燥后的沙棘粉投入粉碎机中粉碎，过80目筛即得到沙棘果粉基料；同时将辅料经粉碎机粉碎后，过80目筛备用。
3.如权利要求1所述的沙棘咀嚼片的制作方法，其特征在于，所述的混合，包括以下步骤：将粉碎后的沙棘果粉基料和辅料混合。
4.如权利要求1所述的沙棘咀嚼片的制作方法，其特征在于，所述的造粒，包括以下步骤：将混合均匀的沙棘果粉基料和辅料，缓慢加入润湿剂制成软料，制好的软料过10目筛制粒。
5.如权利要求1所述的沙棘咀嚼片的制作方法，其特征在于，所述的干燥，包括以下步骤：将湿粒置于45-50℃热风干燥箱中干燥，25-30min翻动一次，以加快干燥速度，以颗粒水分降至3-5％为干燥终点。
6.如权利要求1所述的沙棘咀嚼片的制作方法，其特征在于，所述的压片，包括以下步骤：在干燥颗粒中加入硬脂酸镁作为润滑剂，混合均匀，送入压片机中压片，灭菌后包装，即为成品。
7.如权利要求2所述的沙棘咀嚼片的制作方法，其特征在于，所述的辅料，包括以下主要成分：糖霜、羧甲基纤维素钠、苹果酸、糊精、黄酮粉、乳酸钙、柠檬酸。
8.如权利要求4所述的沙棘咀嚼片的制作方法，其特征在于，所述的润湿剂为乙醇。
9.如权利要求1所述的沙棘咀嚼片的制作方法，其特征在于，所述的沙棘咀嚼片，包括以下重量比的成分：沙棘粉45-60g，羧甲基纤维素钠3-8g，柠檬酸1-3g，苹果酸1-3g，糖霜40-60g，糊精45-55g，乳酸钙3-7g，黄酮粉2-5g，硬脂酸镁0.5-2g。
10.如权利要求1所述的沙棘咀嚼片的制作方法，其特征在于，所述的沙棘咀嚼片，包括以下重量比的成分：沙棘粉50g，羧甲基纤维素钠5g，柠檬酸2g，苹果酸2g，糖霜50g，糊精50g，乳酸钙5g，黄酮粉4g，硬脂酸镁1g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611023842.4A CN106722444A (zh) | 2016-11-17 | 2016-11-17 | 一种沙棘咀嚼片的制作方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611023842.4A CN106722444A (zh) | 2016-11-17 | 2016-11-17 | 一种沙棘咀嚼片的制作方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106722444A true CN106722444A (zh) | 2017-05-31 |
Family
ID=58969882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611023842.4A Pending CN106722444A (zh) | 2016-11-17 | 2016-11-17 | 一种沙棘咀嚼片的制作方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106722444A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109588714A (zh) * | 2019-02-20 | 2019-04-09 | 吉林大学 | 一种具有抗衰老功能的人参果粉咀嚼片及其制备方法 |
| CN110024897A (zh) * | 2019-05-08 | 2019-07-19 | 宝得瑞（湖北）健康产业有限公司 | 一种含沙棘果油的压片糖果及其制备方法 |
| CN110801025A (zh) * | 2019-12-04 | 2020-02-18 | 甘肃有色冶金职业技术学院 | 一种藜麦咀嚼片及其制备方法 |
| CN110839742A (zh) * | 2019-11-29 | 2020-02-28 | 宣城柏维力生物工程有限公司 | 一种沙棘压片糖果的制备方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102907676A (zh) * | 2012-11-13 | 2013-02-06 | 沈阳信达信息科技有限公司 | 一种沙棘咀嚼片的制备方法 |
| CN104187716A (zh) * | 2014-08-12 | 2014-12-10 | 袁怀波 | 一种纯天然全果沙棘咀嚼片及其制备方法 |
| CN105769970A (zh) * | 2016-03-14 | 2016-07-20 | 江苏中邦制药有限公司 | 一种罗汉果咀嚼片及其制备方法 |
| CN105876787A (zh) * | 2013-09-16 | 2016-08-24 | 周杰 | 石斛复合咀嚼片及其制备方法 |
-
2016
- 2016-11-17 CN CN201611023842.4A patent/CN106722444A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102907676A (zh) * | 2012-11-13 | 2013-02-06 | 沈阳信达信息科技有限公司 | 一种沙棘咀嚼片的制备方法 |
| CN105876787A (zh) * | 2013-09-16 | 2016-08-24 | 周杰 | 石斛复合咀嚼片及其制备方法 |
| CN104187716A (zh) * | 2014-08-12 | 2014-12-10 | 袁怀波 | 一种纯天然全果沙棘咀嚼片及其制备方法 |
| CN105769970A (zh) * | 2016-03-14 | 2016-07-20 | 江苏中邦制药有限公司 | 一种罗汉果咀嚼片及其制备方法 |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109588714A (zh) * | 2019-02-20 | 2019-04-09 | 吉林大学 | 一种具有抗衰老功能的人参果粉咀嚼片及其制备方法 |
| CN110024897A (zh) * | 2019-05-08 | 2019-07-19 | 宝得瑞（湖北）健康产业有限公司 | 一种含沙棘果油的压片糖果及其制备方法 |
| CN110839742A (zh) * | 2019-11-29 | 2020-02-28 | 宣城柏维力生物工程有限公司 | 一种沙棘压片糖果的制备方法 |
| CN110801025A (zh) * | 2019-12-04 | 2020-02-18 | 甘肃有色冶金职业技术学院 | 一种藜麦咀嚼片及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| He et al. | Research progress on the health function of tea oil | |
| JP6873517B2 (ja) | 成年女性、高齢者及び亜健康状態の人々に適用できる健康保持製品組成物 | |
| CN106722444A (zh) | 一种沙棘咀嚼片的制作方法 | |
| CN103501800A (zh) | 美肌促进剂及其利用 | |
| CN102058631B (zh) | 沙棘叶提取物制剂及其制备方法 | |
| KR101168169B1 (ko) | 복분자유 조성물, 이의 용도 및 제조방법 | |
| CN110150664A (zh) | 一种改善痤疮的玫瑰花功能食品 | |
| KR100522579B1 (ko) | 항스트레스 효과를 갖는 황금 및 오미자 혼합 추출물을함유하는 약학조성물 | |
| JP6108352B2 (ja) | 疲労改善組成物 | |
| CN106418335A (zh) | 一种沙棘果粉的制作方法 | |
| CN105901722A (zh) | 一种预防老年痴呆症的南极磷虾油保健胶囊 | |
| CN106561967A (zh) | 一种沙棘冰棍的制作方法 | |
| KR100975426B1 (ko) | 생약 추출물을 이용한 알러지성 피부질환 예방 및 치료용조성물 | |
| CN105962237A (zh) | 蜂王浆蜂胶苦瓜含片及其制备方法 | |
| CN107115383B (zh) | 具有防治皮肤干燥综合征功效的皮肤养护/治疗组合物 | |
| KR20150120741A (ko) | 감 껍질, 감 과육, 감잎 및 고욤잎의 혼합물을 유효성분으로 함유하는 아토피 피부염 예방 또는 개선용 조성물 | |
| KR20180133271A (ko) | 생약 추출물 및 분말을 이용한 강정제와 그에 따른 제조방법 | |
| JP7452777B2 (ja) | 生活の質改善又は維持用組成物 | |
| CN108065209A (zh) | 一种调节血脂和抗疲劳的保健食品 | |
| KR101425047B1 (ko) | 로도덴드론 알붐 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 조성물 | |
| JP4310567B2 (ja) | 血中脂質改善剤 | |
| CN101028313A (zh) | 一种具有降血脂及抗氧化功能的超临界蜂胶液配方及工艺 | |
| BATUBARA et al. | Evolving potential functional foods to meet modern needs in commercial product | |
| JP2004033073A (ja) | ウナギ骨髄オイルを含有する栄養補助食品 | |
| CN1057217C (zh) | 沙棘蛋黄保健油及其制造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170531 |